Patent details
EP2270026 Title: Compounds for proteasome enzyme inhibition
Basic Information
- Publication number:
- EP2270026
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP100124973
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- Compounds for proteasome enzyme inhibition
- French Title of Invention:
- Composés pour inhibition d'enzyme de protéasome
- German Title of Invention:
- Verbindungen zur Proteasomenzyminhibition
- SPC Number:
Dates
- Filing date:
- 08/08/2005
- Grant date:
- 18/05/2016
- EP Publication Date:
- 18/05/2016
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 05/01/2011
- EP B1 Publication Date:
- 18/05/2016
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 08/08/2016
- Expiration date:
- 08/08/2025
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 08/08/2005
- Name:
- Onyx Therapeutics Inc.
- Address:
- 249 E. Grand Avenue, South San Francisco, CA 94080, United States (US)
Inventor
1
- Name:
- Smyth Mark S.
- Address:
- United States (US)
2
- Name:
- Laidig Guy J.
- Address:
- United States (US)
Priority
1
- Priority Number:
- 599401 P
- Priority Date:
- 06/08/2004
- Priority Country:
- United States (US)
2
- Priority Number:
- 610001 P
- Priority Date:
- 14/09/2004
- Priority Country:
- United States (US)
3
- Priority Number:
- 106879
- Priority Date:
- 14/04/2005
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- C07K 5/103;
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|